Does Mounjaro Cause Fatigue?
Mounjaro can cause fatigue in some patients. Clinical trials report tiredness in approximately 5 to 9 percent of participants, with rates increasing at higher doses. Fatigue is most common during early treatment and dose increases, and it generally improves as the body adjusts to the medication.
Detailed Explanation
Mounjaro is the brand name for tirzepatide approved for type 2 diabetes management. It is a dual GIP/GLP-1 receptor agonist that works by activating two incretin pathways to improve blood sugar control and, as a secondary benefit, promote weight loss. While gastrointestinal symptoms are the most commonly discussed side effects, fatigue is a recognized adverse reaction listed in the prescribing information.
Clinical Evidence
In the SURPASS clinical trial program, which tested Mounjaro at 5 mg, 10 mg, and 15 mg doses in patients with type 2 diabetes, fatigue was reported across all dose groups at rates higher than placebo. The SURPASS-1 through SURPASS-5 trials collectively enrolled thousands of patients and consistently identified tiredness as an adverse event. The prescribing label lists fatigue among the adverse reactions reported in at least 5 percent of treated patients at some dose levels.
Why Mounjaro Causes Fatigue
For diabetes patients on Mounjaro, there are specific factors that can drive fatigue. The medication substantially lowers blood glucose levels, and patients whose A1C has been elevated for a prolonged period may temporarily feel tired as their blood sugar normalizes. The body has adapted to higher glucose levels, and the rapid correction can mimic symptoms of low blood sugar even when levels are technically in the normal range.
Appetite suppression is another major factor. Mounjaro reduces food intake significantly, and the resulting caloric deficit can produce tiredness, especially when protein intake drops. Patients with diabetes who also take insulin or sulfonylureas alongside Mounjaro have an increased risk of true hypoglycemia, which can cause fatigue, shakiness, and weakness.
Managing Fatigue on Mounjaro
The gradual dose-titration schedule (starting at 2.5 mg and increasing every four weeks) is designed to minimize side effects including fatigue. Patients who experience severe tiredness at a particular dose level can work with their physician to extend the time at that dose before increasing further. Most patients find that their energy normalizes within four to six weeks of reaching their maintenance dose.
What to Consider
- Monitor blood sugar levels closely, especially if you take other diabetes medications that can cause hypoglycemia.
- Maintain adequate caloric intake even when appetite is reduced. Your physician or a registered dietitian can help determine appropriate targets.
- Stay hydrated, as nausea and reduced appetite can lead to decreased fluid intake.
- Report fatigue to your prescribing physician, especially if it is accompanied by dizziness, confusion, sweating, or rapid heartbeat, which may indicate low blood sugar.
- Consider spacing meals evenly throughout the day to prevent energy dips.
- Your physician may adjust the doses of other diabetes medications when adding Mounjaro to reduce the risk of hypoglycemia-related fatigue.
Physician-Supervised Mounjaro Therapy
FormBlends offers tirzepatide therapy with ongoing physician oversight, including blood sugar monitoring and personalized dose management. Start with a telehealth consultation to discuss whether Mounjaro is appropriate for your needs.
Schedule a Consultation at FormBlends.com